Workflow
Nestle(NSRGY)
icon
Search documents
Nestlé: New CEO's Strategic Pivot Strengthens The Buy Case
Seeking Alpha· 2025-12-03 12:13
Group 1 - The analyst has over 10 years of experience researching more than 1000 companies across various sectors including commodities and technology [1] - The focus has shifted from writing a blog to creating a value investing-focused YouTube channel, covering hundreds of companies [1] - The analyst expresses a particular interest in metals and mining stocks, while also being comfortable with consumer discretionary, staples, REITs, and utilities [1]
八年“联姻”走到十字路口,雀巢或剥离蓝瓶咖啡
Guan Cha Zhe Wang· 2025-12-03 10:29
据外媒最新消息,全球食品与饮料巨头雀巢公司正与华尔街投资银行摩根大通展开合作,对旗下高端咖啡连锁品牌蓝瓶咖啡(Blue Bottle Coffee)的未来进行 战略性评估,其中潜在的出售选项已成为核心议题。 知情人士透露,此次评估尚处于早期阶段,但出售的可能性已被摆上台面。对此,观察者网向雀巢集团方面求证,相关负责人表示"这个情况我们也在内部 问"。 资料显示,蓝瓶咖啡是美国精品咖啡连锁品牌,由单簧管演奏家詹姆斯.弗里曼(James Freeman)创立于2002年。 根据当时的公告,2016年时,蓝瓶咖啡只在美国主要城市和日本开设了店铺,门店数为29家。雀巢收购之后,蓝瓶咖啡将在运营上保持独立,并计划在2017 年底前将店铺总数拓展至55家。 时任雀巢公司CEO的马克.施耐德(Mark Schneider)对该交易寄予厚望,他表示:"此举彰显了雀巢投资聚焦于高增长类别并紧跟消费趋势。蓝瓶咖啡追求品质 咖啡的激情和具有使命感的前瞻意识是他们品牌获得巨大成功的基石。他们的规模化道路已经非常明晰,而这得益于消费者日益提高的咖啡品味和对可持续 咖啡的青睐。" 当时分析也普遍看好,认为雀巢传统优势在于零售产品和速溶咖 ...
雀巢婴儿营养与惠氏营养品在华合并,意在重拾增长势头
Xin Jing Bao· 2025-12-03 09:43
近日有消息传出,雀巢大中华区将于2026年1月1日起成立雀巢营养品业务单元,其中一项重要举措是将 雀巢和惠氏两大婴儿营养业务进行合并,由雀巢婴儿营养业务负责人谢国耀担任新业务部门负责人。12 月2日,雀巢方面向新京报记者证实了上述消息,并称婴儿营养始终是其核心业务,此次整合将帮助其 重拾增长势头。 资料显示,自2012年被雀巢收购以来,惠氏营养品一直保持独立运作,一度借助高端品类稳坐中国婴幼 儿奶粉市场第一宝座。2019年-2021年,受人口出生率下降、国产奶粉品牌崛起及市场竞争加剧等因素 影响,惠氏主要系列产品在中国市场销量出现下滑。经过一系列策略调整,雀巢大中华区婴幼儿营养业 务2022年、2023年实现复苏,但2024年再次下降。第三方数据显示,截至2024年底,雀巢、惠氏在中国 婴幼儿奶粉市场整体份额位列第四,但单独品牌份额已分别掉落至第七、第八位。 此次合并之所以受到外界关注,在于惠氏营养品被雀巢收购的过往13年里,一直独立运作于雀巢婴儿营 养业务之外。 分析认为,雀巢与惠氏婴儿营养业务在中国市场合并,主要目的是提高组织效率,实现"降本增效",提 高整体有效竞争力。 收购13年后首次业务合并 雀巢方 ...
新帅在华“动刀”:雀巢、惠氏营养品合并
雀巢正在经历一场自上而下的大改革。 2025年12月1日,雀巢中国向21世纪经济报道记者确认,惠氏营养品业务和雀巢婴儿营养品业务两大业 务单元将于2026年1月1日起正式合并,成立雀巢营养品业务。谢国耀(Joel Seah)将成为该业务的负责 人。 对此,雀巢大中华区董事长兼首席执行官马凯思向员工表示:"这不是倒退,而是为了一个更加美好的 开篇。" "婴儿营养始终是我们的核心业务,我们将继续加大对品牌和渠道的投资。在业务调整过程中,公司严 格依法合规执行。调整不影响现有业务开展,惠氏营养品(中国)有限公司和惠氏(上海)贸易有限公 司将继续运行,惠氏启赋、S-26等品牌将继续服务中国消费者。"雀巢方面如此向21世纪经济报道记者 回应称。 竞争变难 "这一整合将帮助我们重拾增长势头,巩固在中国婴儿营养市场的领导地位。"对于此次整合,雀巢中国 如此解释。 背后是,雀巢婴儿营养板块的核心市场婴配粉行业正走向存量。 毕竟,在婴配粉市场,国产品牌已经占据主导位置。欧睿数据显示,飞鹤、伊利早在2022年就已超越外 资跻身前二。 由此,对雀巢中国来说,将惠氏营养品业务与雀巢婴儿营养品业务两大业务单元合并,有助于减少内 耗,形 ...
82岁爱马仕继承人被骗150亿美元细节曝光;盒马鲜生前CEO李卫平掌舵高鑫零售丨消费早参
Mei Ri Jing Ji Xin Wen· 2025-12-02 21:00
NO.2 82岁爱马仕继承人被骗150亿美元细节曝光 近日,爱马仕第五代继承人尼古拉·皮埃什被骗150亿美元的惊人案件细节逐渐浮出水面。他公开指控 称,自己曾拥有的大量爱马仕股份已经"蒸发",而他曾信任了长达25年的财富管理人埃里克·弗雷蒙德 是幕后"玩弄阴谋诡计"的罪魁祸首。 点评:对奢侈品板块,此案暴露了超高端财富管理中的信任风险与监管漏洞,将推动行业头部企业强化 股权锁定与内控机制。对于股市整体而言,这一极端案例为高净值人群资产配置敲响警钟,也让市场更 重视上市公司股权结构透明度与委托理财风险管控。 NO.3 美可卓蓝胖子回应假奶粉事件 近期,部分网上直播间及非正规渠道销售的"蓝胖子"奶粉涉嫌假冒伪劣,"假奶粉奶精加淀粉"相关话题 引发社会关注。12月1日,据报道,美可卓专卖店店铺工作人员对假奶粉报道回应称,Maxigenes美可卓 蓝胖子奶粉是100%澳大利亚原装进口的正规产品。为了确保消费者购买到100%正品,强烈建议通过美 可卓官方授权的渠道购买,并认准美可卓品牌。 |2025年12月2日星期二| NO.1惠氏营养品和雀巢婴儿营养品在中国市场将迎来合并 12月1日,据报道,根据最新安排,在大中华区 ...
雀巢,联合作战
Sou Hu Cai Jing· 2025-12-02 17:07
12月2日,雀巢方面向《消费钛度》证实称,雀巢将迎来新的组织架构调整:在大中华区市场,惠氏营 养品业务和雀巢婴儿营养品业务计划合并,并于2026年1月1日正式成立雀巢营养品业务,深耕母婴市场 多年的老将谢国耀(Joel Seah)将成为该业务的负责人。 这一整合动作,不仅标志着两大外资营养品巨头在华业务的深度融合,更被视作外资品牌应对中国市场 变局的关键落子。这场"联合作战"能否改写行业格局,成为市场关注的核心焦点。在业内人士看来,雀 巢与惠氏的合并具有显著的协同效应,新业务单元有望通过品牌、产品、渠道的三重整合打开增长空 间。 从收购到合并 作为雀巢旗下定位于高端奶粉的品牌,惠氏于2012年被雀巢以118.5亿美元从辉瑞旗下收购,收购完成 后,惠氏保持独立运营,雀巢对其进行"嵌入式"管理,让惠氏保留品牌、渠道、团队独立性,雀巢与其 共享渠道、供应链资源。 目前,惠氏旗下主要有惠氏启赋、S-26等品牌。而雀巢自身婴儿营养品旗下品牌则包括雀巢能恩、嘉宝 等,主要聚焦于婴幼儿营养和特殊医学用途配方奶粉。 此次合并的核心掌舵者谢国耀,其履历背景为这场整合增添了更多确定性。据悉,谢国耀拥有超过20年 快消品行业经验, ...
雀巢被指考虑出售蓝瓶咖啡,在中国内地市场门店已拓展到三个城市
3 6 Ke· 2025-12-02 03:56
对于雀巢集团来说,业务评估的帷幕正次第拉开。 今天最新传来的消息,是这家全球最大的食品公司被指正考虑出售蓝瓶咖啡(Blue Bottle Coffee)。据今天路透引述"三位知情人士"透露,雀巢正与投资 银行摩根士丹利合作,实施本次评估。 今天,小食代翻查资料显示,雀巢是在2017年以约4.25亿美元收购了蓝瓶咖啡68%股份。目前,蓝瓶咖啡在中国已经有10多家门店,最新进入的城市是杭 州。在本次传言之前,蓝瓶咖啡的运作相对独立,除了自行决定开店节奏外,也有权对中国市场掌门人进行任命。 不过,蓝瓶咖啡也和雀巢业务存在一定协同。据路透今天的说法,雀巢也可能会保留蓝瓶咖啡品牌的知识产权,因此评估或只是门店业务。下面,我们就 看看最新的传言。 先看看路透的说法。 "我们在中国的审慎扩张体现了蓝瓶咖啡理念:每家咖啡馆都应当提供植根于精湛手艺、热情好客和卓越设计的美好体验。"今年,蓝瓶咖啡全球首席执行 官Karl Strovink说道,这解释了公司对在华开店节奏的把握。 传言 今天早间,路透引述"三位知情人士"透露,瑞士食品巨头雀巢正与摩根士丹利合作,评估旗下蓝瓶咖啡连锁的各种选项,其中包括可能的出售。对此,雀 巢与摩根 ...
外资奶粉在中国不香了,昔日一哥惠氏将被雀巢合并
Guan Cha Zhe Wang· 2025-12-02 01:57
Core Insights - Nestlé Group is integrating its Wyeth Nutrition and Nestlé Infant Nutrition units to form a new "Nestlé Nutrition" team in China starting January 1, 2026, with Joel Seah as the head of the merged business [1] - The integration aims to enhance growth momentum and strengthen Nestlé's leadership position in the Chinese infant nutrition market [1] Financial Performance - Nestlé's global sales for the first nine months of 2025 were 65.9 billion Swiss francs, a year-on-year decline of approximately 1.9% [1] - The Greater China region experienced an organic growth rate of -6.1%, with an internal growth rate of -2.9% and a pricing contribution rate of -3.2% [1] Strategic Changes - New CEO Philipp Navratil has prioritized improving internal growth rates and is implementing a comprehensive strategy to streamline operations, eliminate inefficiencies, and maximize the value of existing assets [2] - The focus is shifting from expensive non-organic growth to leveraging synergies and enhancing profitability across existing business units [2] Market Challenges - The Chinese infant formula market is facing challenges such as declining birth rates and increased competition, leading to a further decline in Wyeth's market share [2] - The market dynamics have shifted significantly, with domestic brands gaining ground and foreign brands like Wyeth experiencing a drop in market presence [2] Competitive Landscape - In 2019, the market shares of Feihe and Nestlé were nearly equal at 13.3% and 13.5%, respectively; however, by 2022, Feihe's market share increased to 17.5%, while Nestlé's fell to 10.7% [3] - The implementation of new national standards for infant formula presents an opportunity for Wyeth, as it was the first foreign brand to have all its products registered under the new standards [3] Operational Continuity - The restructuring will not affect the ongoing operations of Wyeth Nutrition (China) Co., Ltd. and Wyeth (Shanghai) Trading Co., Ltd., and brands like Wyeth Illuma and S-26 will continue to serve Chinese consumers [4]
植物肉退潮!别样肉客关旗舰店 雀巢联合利华相关业务暂停
Nan Fang Du Shi Bao· 2025-12-01 14:00
Core Viewpoint - Beyond Meat, known as the "first plant-based meat stock," has independently terminated its Tmall flagship store operations, reflecting a significant retreat from the Chinese market due to declining demand for plant-based products [1][5][8]. Group 1: Business Operations - Beyond Meat announced in February that it would suspend operations in China by the end of June, planning to reduce its workforce by 95% [5][8]. - The company had previously viewed China as a strategic market, launching products in collaboration with major brands like Starbucks and KFC [6][7]. - As of November 27, Beyond Meat's Tmall flagship store ceased operations, and its Pinduoduo store no longer sells any products [1][8]. Group 2: Market Challenges - The demand for plant-based meat in China has significantly declined, with major partners like Starbucks, KFC, and Nestlé halting or selling off their plant-based product lines [9][12][14]. - Beyond Meat's revenue has been on a downward trend since 2022, with projected revenues of $4.65 billion in 2021, dropping to $3.27 billion in 2024, and net losses increasing from $1.82 billion to $1.60 billion over the same period [9][11]. - In the U.S. market, Beyond Meat has also experienced a decline in sales, with retail channel revenues down 18.4% and food service revenues down 27.3% in the latest quarter [11]. Group 3: Industry Trends - The overall market for plant-based meat in China is cooling, with various brands, including local ones, also facing challenges in maintaining product offerings [12][13]. - Nestlé and Unilever have both scaled back their plant-based meat initiatives in China, indicating a broader industry trend of reassessing the market potential for plant-based products [13][14].
新帅在华动刀:雀巢、惠氏营养品合并
Core Viewpoint - Nestlé is undergoing a significant restructuring, merging its Wyeth Nutrition and Nestlé Infant Nutrition units into a single Nestlé Nutrition business starting January 1, 2026, to enhance growth and consolidate its leadership in the Chinese infant nutrition market [1][9]. Group 1: Business Restructuring - The merger aims to reduce internal competition and leverage the strong brand influence of Wyeth and the operational advantages of Nestlé's infant nutrition team [10][9]. - Joel Seah will lead the newly formed Nestlé Nutrition business [1]. - The restructuring is part of a broader strategy to prioritize high-potential opportunities and foster a performance-oriented culture within the company [13]. Group 2: Market Dynamics - The infant formula market in China is experiencing stagnation, with a growth rate of only 0.6% in Q2 2025, as the new birth rate declines and marriage registrations drop by over 20% in 2024 [4]. - The ultra-premium segment is becoming mainstream, with a 13.3% year-on-year growth in the ultra-premium+ market, while other segments are declining [5]. - Domestic brands like Feihe and Yili have surpassed foreign brands in market share, indicating a shift in competitive dynamics [8]. Group 3: Financial Performance - Nestlé's organic growth rate in the Greater China region was -10.4% in Q3, continuing a downward trend from Q2, highlighting the operational pressures faced by the company [10]. - The overall sales figures for the first nine months of 2025 show a slight decline compared to the same period in 2024, with total sales of 65,869 million Swiss francs [3]. Group 4: Leadership Changes - Recent leadership changes include the appointment of a new CEO, who emphasizes a cautious approach to resource allocation and a focus on growth [12][13]. - The restructuring is being executed under the guidance of the new management team, which includes key personnel with experience in the Southeast Asian market [16][15].